Daneshgari F, Liu G, Birder L, Hanna-Mitchell AT, Chacko S. “Diabetic bladder dysfunction: current translational knowledge,” (in eng). J Urol. 2009;182(6 Suppl):S18-26. https://doi.org/10.1016/j.juro.2009.08.070.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu D, Gao J, Wang X, Huang L, Wang K. Prevalence of overactive bladder and its impact on quality of life in 1025 patients with type 2 diabetes in mainland China. J Diabetes Complications. 2017;31(8):1254–8. https://doi.org/10.1016/j.jdiacomp.2017.05.001.

Article  PubMed  Google Scholar 

Kupelian V, et al. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med. 2006;166(21):2381–7. https://doi.org/10.1001/archinte.166.21.2381.

Article  PubMed  Google Scholar 

Jacobson AM, et al. Relationship of urologic complications with health-related quality of life and perceived value of health in men and women with type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Interventions and Complications (DCCT/EDIC) cohort. Diabetes Care. 2015;38(10):1904–12. https://doi.org/10.2337/dc15-0286.

Article  PubMed  PubMed Central  Google Scholar 

Hill SR, Fayyad AM, Jones GR. Diabetes mellitus and female lower urinary tract symptoms: a review. Neurourol Urodyn. 2008;27(5):362–7. https://doi.org/10.1002/nau.20533.

Article  PubMed  Google Scholar 

Tanaka Y, et al. Association of lower urinary tract symptoms based on the international prostate symptom score and cardiovascular disease. Circ J. 2021;85(11):2092–9. https://doi.org/10.1253/circj.CJ-21-0278.

Article  PubMed  Google Scholar 

Akerla J, et al. Lower urinary tract symptoms and mortality among finnish men: the roles of symptom severity and bother. J Urol. 2022;207(6):1285–94. https://doi.org/10.1097/JU.0000000000002450.

Article  PubMed  Google Scholar 

Chung MS, Chuang YC, Lee JJ, Lee WC, Chancellor MB, Liu RT. Prevalence and associated risk factors of nocturia and subsequent mortality in 1,301 patients with type 2 diabetes. Int Urol Nephrol. 2014;46(7):1269–75. https://doi.org/10.1007/s11255-014-0669-2.

Article  PubMed  Google Scholar 

Lee WC, Wu HP, Tai TY, Liu SP, Chen J, Yu HJ. Effects of diabetes on female voiding behavior. J Urol. 2004;172(3):989–92. https://doi.org/10.1097/01.ju.0000136255.83054.0c.

Article  PubMed  Google Scholar 

Appa AA, et al. Clinical predictors and significance of postvoid residual volume in women with diabetes. Diabetes Res Clin Pract. 2013;101(2):164–9. https://doi.org/10.1016/j.diabres.2013.05.005.

Article  PubMed  PubMed Central  Google Scholar 

Sorrentino F, et al. “Associations between individual lower urinary tract symptoms and bacteriuria in random urine samples in women,” (in eng). Neurourol Urodyn. 2015;34(5):429–33. https://doi.org/10.1002/nau.22607.

Article  PubMed  Google Scholar 

Ishida S, et al. Urodynamic risk factors of asymptomatic bacteriuria in men with non-neurogenic lower urinary tract symptoms. World J Urol. 2022;40(12):3035–41. https://doi.org/10.1007/s00345-022-04194-x.

Article  PubMed  Google Scholar 

N. C. Chilelli et al., "Lower urinary tract symptoms (LUTS) in males with type 2 diabetes recently treated with SGLT2 inhibitors-overlooked and overwhelming? A retrospective case series," (in eng), Endocrine, vol. 59, no. 3, pp. 690–693, 03 2018, https://doi.org/10.1007/s12020-017-1301-x.

Tsunoda A. Bidet Toilet Use May Cause Anal Symptoms and Nosocomial Infection. J Anus Rectum Colon. 2021;5(4):335–9. https://doi.org/10.23922/jarc.2021-027.

Article  PubMed  PubMed Central  Google Scholar 

S. E. Geerlings et al., "Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group," (in eng), Diabetes Care, vol. 23, no. 6, pp. 744–9, Jun 2000, https://doi.org/10.2337/diacare.23.6.744.

Renko M, Tapanainen P, Tossavainen P, Pokka T, Uhari M. “Meta-analysis of the significance of asymptomatic bacteriuria in diabetes,” (in eng). Diabetes Care. 2011;34(1):230–5. https://doi.org/10.2337/dc10-0421.

Article  PubMed  Google Scholar 

Homma Y, et al. Symptom assessment tool for overactive bladder syndrome–overactive bladder symptom score. Urology. 2006;68(2):318–23. https://doi.org/10.1016/j.urology.2006.02.042.

Article  PubMed  Google Scholar 

E. Karantanis, M. Fynes, K. H. Moore, and S. L. Stanton, "Comparison of the ICIQ-SF and 24-hour pad test with other measures for evaluating the severity of urodynamic stress incontinence," Int Urogynecol J Pelvic Floor Dysfunct, vol. 15, no. 2, pp. 111–6; discussion 116, Mar-Apr 2004, https://doi.org/10.1007/s00192-004-1123-2.

Okamura K, Usami T, Nagahama K, Maruyama S, Mizuta E. “The relationships among filling, voiding subscores from International Prostate Symptom Score and quality of life in Japanese elderly men and women,” (in eng). Eur Urol. 2002;42(5):498–505. https://doi.org/10.1016/s0302-2838(02)00438-4.

Article  PubMed  Google Scholar 

S. Takahashi et al., "Clinical Guidelines for Female Lower Urinary Tract Symptoms (second edition)," Int J Urol, vol. 28, no. 5, pp. 474–492, May 2021, doi: https://doi.org/10.1111/iju.14492.

James R, Hijaz A. Lower urinary tract symptoms in women with diabetes mellitus: a current review. Curr Urol Rep. 2014;15(10):440. https://doi.org/10.1007/s11934-014-0440-3.

Article  PubMed  Google Scholar 

Dai M, et al. Incidence and risk factors of asymptomatic bacteriuria in patients with type 2 diabetes mellitus: a meta-analysis. Endocrine. 2023;82(2):263–81. https://doi.org/10.1007/s12020-023-03469-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ishay A, Lavi I, Luboshitzky R. Prevalence and risk factors for asymptomatic bacteriuria in women with Type 2 diabetes mellitus. Diabet Med. 2006;23(2):185–8. https://doi.org/10.1111/j.1464-5491.2005.01758.x.

Article  CAS  PubMed  Google Scholar 

Tai HC, et al. “Metabolic syndrome components worsen lower urinary tract symptoms in women with type 2 diabetes,” (in eng). J Clin Endocrinol Metab. 2010;95(3):1143–50. https://doi.org/10.1210/jc.2009-1492.

Article  CAS  PubMed  Google Scholar 

Feng T, et al. Serum cholesterol and risk of lower urinary tract symptoms progression: results from the Reduction by Dutasteride of Prostate Cancer Events study. Int J Urol. 2017;24(2):151–6. https://doi.org/10.1111/iju.13265.

Article  CAS  PubMed  Google Scholar 

E. Papaefstathiou, K. Moysidis, P. Sarafis, E. Ioannidis, and K. Hatzimouratidis, "The impact of Diabetes Mellitus on Lower urinary tract symptoms (LUTS) in both male and female patients," Diabetes Metab Syndr, vol. 13, no. 1, pp. 454–457, Jan - Feb 2019, doi: https://doi.org/10.1016/j.dsx.2018.11.009.

Nomiya M, Andersson KE, Yamaguchi O. Chronic bladder ischemia and oxidative stress: new pharmacotherapeutic targets for lower urinary tract symptoms. Int J Urol. 2015;22(1):40–6. https://doi.org/10.1111/iju.12652.

Article  CAS  PubMed  Google Scholar 

Azab S. The impact of atherosclerosis on lower urinary tract function. Aging Male. 2013;16(3):108–11. https://doi.org/10.3109/13685538.2013.795532.

Article  CAS  PubMed  Google Scholar 

Andersson KE, Boedtkjer DB, Forman A. The link between vascular dysfunction, bladder ischemia, and aging bladder dysfunction. Ther Adv Urol. 2017;9(1):11–27. https://doi.org/10.1177/1756287216675778.

Article  CAS  PubMed  Google Scholar 

Kasyan G, Berketova TY, Rogozin AK, Pushkar DY. Asymptomatic bacteriuria in postmenopausal women with diabetes mellitus. Cent European J Urol. 2013;66(3):320–6. https://doi.org/10.5173/ceju.2013.03.art17.

Article  PubMed  PubMed Central  Google Scholar 

Ligon MM, Joshi CS, Fashemi BE, Salazar AM, Mysorekar IU. Effects of aging on urinary tract epithelial homeostasis and immunity. Dev Biol. 2023;493:29–39. https://doi.org/10.1016/j.ydbio.2022.11.003.

Article  CAS  PubMed  Google Scholar 

Soma O, et al. Relationship between frailty and lower urinary tract symptoms among community-dwelling adults. Low Urin Tract Symptoms. 2020;12(2):128–36. https://doi.org/10.1111/luts.12292.

Article  PubMed  Google Scholar 

Tai HC, Tai TY, Yang WS, Wang SW, Yu HJ. “Associations between lower urinary tract dysfunction and glycemic control in women with type 2 diabetes: a cross-sectional study,” (in eng). J Diabetes Complications. 2016;30(3):415–9. https://doi.org/10.1016/j.jdiacomp.2016.01.002.

Article  PubMed  Google Scholar 

V. Hall, J. Kwong, D. Johnson, and E. I. Ekinci, "Caution advised with dapagliflozin in the setting of male urinary tract outlet obstruction," (in eng), BMJ Case Rep, vol. 2017, May 2017, doi: https://doi.org/10.1136/bcr-2017-219335.

Huang Z, Xiao H, Li H, Yan W, Ji Z. Analysis of the incidence and risk factors of male urinary tract infection following urodynamic study. Eur J Clin Microbiol Infect Dis. 2017;36(10):1873–8. https://doi.org/10.1007/s10096-017-3007-7.

Article  CAS  PubMed  Google Scholar 

Stern JA, Hsieh YC, Schaeffer AJ. Residual urine in an elderly female population: novel implications for oral estrogen replacement and impact on recurrent urinary tract infection. J Urol. 2004;171(2 Pt 1):768–70. https://doi.org/10.1097/01.ju.0000107261.64927.b3.

Article  CAS  PubMed  Google Scholar 

A. D. Kaze, M. Zhuo, S. C. Kim, E. Patorno, and J. M. Paik, "Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis," Cardiovasc Diabetol, vol. 21, no. 1, p. 47, Mar 23 2022, doi: https://doi.org/10.1186/s12933-022-01476-x.

Li D, Wang T, Shen S, Fang Z, Dong Y, Tang H. Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2017;19(3):348–55. https://doi.org/10.1111/dom.12825.

Article  CAS  PubMed  Google Scholar 

Vasilakou D, et al. “Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis,” (in eng). Ann Intern Med. 2013;159(4):262–74. https://doi.org/10.7326/0003-4819-159-4-201308200-00007.

Article  PubMed